Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism

被引:0
作者
Suresh Vedantham
Gregory Piazza
Akhilesh K. Sista
Neil A. Goldenberg
机构
[1] Washington University School of Medicine,Mallinckrodt Institute of Radiology
[2] Harvard Medical School,undefined
[3] Weill Cornell Medical College,undefined
[4] Johns Hopkins School of Medicine,undefined
来源
Journal of Thrombosis and Thrombolysis | 2016年 / 41卷
关键词
Venous thromboembolism; Pulmonary embolism; Thrombolytic therapy; Anticoagulants; Direct oral anticoagulants (DOAC); New oral anticoagulants (NOAC);
D O I
暂无
中图分类号
学科分类号
摘要
Patients with venous thromboembolism (VTE) are prone to the development of both short-term and long-term complications that can substantially affect their functional capacity and quality of life. Patients with deep vein thrombosis (DVT) often develop recurrent VTE or the post-thrombotic syndrome, whereas patients with pulmonary embolism (PE) can develop long-term symptoms and functional limitations along a broad spectrum extending to full-blown chronic thromboembolic pulmonary hypertension. Clinicians who care for patients showing severe clinical manifestations of DVT and PE are often faced with challenging decisions concerning whether and how to escalate to more aggressive treatments such as those involving the use of thrombolytic drugs. The purpose of this chapter is to provide guidance on how best to individualize care to these patients.
引用
收藏
页码:68 / 80
页数:12
相关论文
共 441 条
  • [1] Huang W(2014)Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE Study (1985–2009) Am J Med 127 829-839:e5
  • [2] Goldberg RJ(2009)Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007 Pediatrics 124 1001-1008
  • [3] Anderson FA(2012)Clinical features and short term outcomes of patients with acute pulmonary embolism. The italian pulmonary embolism registry (iper) Thromb Res 130 847-852
  • [4] Kiefe CI(2013)Acute pulmonary embolism: external validation of an integrated risk stratification model Chest 144 1539-1545
  • [5] Spence FA(2007)The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1626 patients Haematologica 92 199-205
  • [6] Raffini L(2014)30-year mortality after venous thromboembolism: a population-based cohort study Circulation 130 829-836
  • [7] Huang YS(2008)Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis Ann Intern Med 149 698-707
  • [8] Witmer C(2014)The post-thrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies—a scientific statement from the American Heart Association Circulation 130 1636-1661
  • [9] Feudtner D(2010)Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors Haematologica 95 1952-1959
  • [10] Casazza F(2011)Chronic thromboembolic pulmonary hypertension N Engl J Med 364 351-360